10 Years of Rhodococcus: Clinical Trends and Susceptibility Profiles
Rhodococcus infections are uncommon, however they can cause serious disease in certain patients....
37:37
10 Years of Rhodococcus: Clinical Trends and Susceptibility Profiles
Rhodococcus infections are uncommon, however they can cause serious disease in certain patients....
37:37
Phage therapy has gained a lot of traction but the challenges created by this approach have not...
37:31
The protozoan Lophomonas has been reported to be a pathogen of humans in a large number of case...
34:32
Treatment of Multidrug-resistant Tuberculosis
Tuberculosis is one of the most deadly infectious diseases that still causes significant burden...
40:16
New generation B-lactam/B-lactamase inhibitors: Taniborbactam
A new generation of B-lactamase inhibitors is likely to reach the market in the upcoming year....
48:22
Favorite Clinical Microbiology Papers of 2023 (JCM ed.)
We managed to make it through 2023 without a major epidemic or pandemic, and as we get into the...
01:05:15
Antimicrobial Resistance in Neisseria Gonorrhoeae (JCM ed.)
Gonorrhea remains one of the more common sexually transmitted infections. In North America, the...
29:12
In the last few years we have witnessed the rise of very resistant fungal species some of them...
46:47
A Novel Coccidioides Antibody LFA (JCM ed.)
Despite the many advances in diagnostic testing for infectious diseases, detection of Coccidoides...
43:59
Climate Change and Antimicrobial Resistance (AAC ed.)
Climate change is possibly the major threat that planet earth is experiencing in this century...
29:25
Emerging Antifungal-Resistant Dermatophytes (JCM ed.)
Fungi that are resistant to antifungal drugs have been very much in the news and even the subject...
29:25
Artificial Intelligence and Infectious Diseases
Artificial intelligence (AI) has the potential to change the way we practice medicine and public...
38:54
Viral Outbreaks in the Headlines (JCM ed.)
Dr. Elli Theel and Dr. Alex McAdam discuss recent viral outbreaks with expert virologists....
27:53
AAC Launches a New Section Focused On Antimicrobial Stewardship
In response to the global burden of antimicrobial resistance (AMR) and the critical role...
37:13
Susceptibility Testing for Aztreonam with Ceftazidime-Avibactam
The combination of aztreonam with ceftazidime-avibactam is increasingly used for treatment of...
38:55
Hispanic Leadership in Vaccine Sciences With Dr. Maria Elena Bottazzi (AAC ed.)
Recorded at ASM Microbe 2023, Cesar has a conversation with Dr. Maria Elena Bottazzi about the...
28:41
Susceptibility Testing for Aztreonam with Ceftazidime-Avibactam
The combination of aztreonam with ceftazidime-avibactam is increasingly used for treatment of...
41:11
Management of Difficult to Treat HSV and CMV Infections (AAC ed.)
As the number of immunocompromised patients rise in our hospitals, the presentation of severe...
45:44
Susceptibility Testing for Piperacillin-Tazobactam (JCM ed.)
Susceptibility testing for piperacillin-tazobactam has undergone rapid evolution, largely driven...
49:34
Antimicrobial Resistance in Neisseria gonorrhoeae (AAC ed.)
The Center of Diseases Control and Prevention (CDC) has categorized emergent resistance in...
44:49